Search for Clinical Trial Results

Candidiasis, Invasive - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064) Condition: Candidiasis, Invasive Date: 2013-09-13 Interventions:
|
Recruiting |
Study Name: Invasive Candidiasis in ICU Condition: Invasive Candidiasis Date: 2011-12-02 |
Terminated |
Study Name: Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067) Condition: Invasive Candidiasis Date: 2010-01-07 Interventions:
|
Completed |
Study Name: β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients Condition: Invasive Candidiasis Date: 2008-05-04 Interventions:
|
Active, not recruiting |
Study Name: NOBICS - NOvel BIomarker In Invasive CandidiasiS/Candida Sepsis Condition: Invasive Candidiasis Date: 2016-06-09 |
Completed |
Study Name: Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU) Condition: Invasive Candidiasis Date: 2007-08-21 Interventions:
|
Completed |
Study Name: Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study Condition: Invasive Candidiasis Date: 2008-05-29 Interventions:
|
Completed |
Study Name: Evaluate the Performance of Genetic Amplification by Polymerase Chain Reaction (PCR) and the "Mannan Antigenemia and Antimannan Antibodies Couple as a Means of Diagnosis and a Marker of Follow-up in Invasive Candidiasis. Condition: Invasive Candidiasis; Treatment With Echinocandin Date: 2014-12-05 Interventions:
|
Completed |
Study Name: Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia Condition:
Date: 2005-09-12 Interventions:
|
Completed |
Study Name: CRITIC - Treatment of Candidemia and Invasive Candidiasis Condition:
Date: 2008-04-29 Interventions: Drug: AmBisome Patients will receive 2mg/kg/day IV daily administration of AmBisome® over 30-60 min |